Bruserud, Ø.; Tsykunova, G.; Hernandez-Valladares, M.; Reikvam, H.; Tvedt, T.H.A.
Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation. Pharmaceuticals 2021, 14, 423.
https://doi.org/10.3390/ph14050423
AMA Style
Bruserud Ø, Tsykunova G, Hernandez-Valladares M, Reikvam H, Tvedt THA.
Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation. Pharmaceuticals. 2021; 14(5):423.
https://doi.org/10.3390/ph14050423
Chicago/Turabian Style
Bruserud, Øystein, Galina Tsykunova, Maria Hernandez-Valladares, Hakon Reikvam, and Tor Henrik Anderson Tvedt.
2021. "Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation" Pharmaceuticals 14, no. 5: 423.
https://doi.org/10.3390/ph14050423
APA Style
Bruserud, Ø., Tsykunova, G., Hernandez-Valladares, M., Reikvam, H., & Tvedt, T. H. A.
(2021). Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation. Pharmaceuticals, 14(5), 423.
https://doi.org/10.3390/ph14050423